Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is characterized by vascular damage, inflammation and fibrosis of the skin and various internal organs. Interstitial lung disease (ILD) frequently complicates SSc and can be a debilitating disorder with a poor prognosis. ILD is the most frequent cause of death in SSc, and the management of SSc–ILD patients is a great challenge. Early detection of pulmonary involvement based on a recent decline of lung function tests and on the extent of lung involvement at high-resolution computed tomography is critical for the best management of these patients. This article summarizes classification, pathogenesis, diagnosis, prognosis, survival and finally current and future treatment options in SSc–ILD.

Giacomelli, R., Liakouli, V., Berardicurti, O., Ruscitti, P., Di Benedetto, P., Carubbi, F., et al. (2017). Interstitial lung disease in systemic sclerosis: current and future treatment. RHEUMATOLOGY INTERNATIONAL, 37(6), 853-863 [10.1007/s00296-016-3636-7].

Interstitial lung disease in systemic sclerosis: current and future treatment

Guggino, Giuliana;Ciccia, Francesco;Triolo, Giovanni;
2017-01-01

Abstract

Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is characterized by vascular damage, inflammation and fibrosis of the skin and various internal organs. Interstitial lung disease (ILD) frequently complicates SSc and can be a debilitating disorder with a poor prognosis. ILD is the most frequent cause of death in SSc, and the management of SSc–ILD patients is a great challenge. Early detection of pulmonary involvement based on a recent decline of lung function tests and on the extent of lung involvement at high-resolution computed tomography is critical for the best management of these patients. This article summarizes classification, pathogenesis, diagnosis, prognosis, survival and finally current and future treatment options in SSc–ILD.
2017
Settore MED/16 - Reumatologia
Giacomelli, R., Liakouli, V., Berardicurti, O., Ruscitti, P., Di Benedetto, P., Carubbi, F., et al. (2017). Interstitial lung disease in systemic sclerosis: current and future treatment. RHEUMATOLOGY INTERNATIONAL, 37(6), 853-863 [10.1007/s00296-016-3636-7].
File in questo prodotto:
File Dimensione Formato  
10.1007%2Fs00296-016-3636-7.pdf

Solo gestori archvio

Dimensione 484.77 kB
Formato Adobe PDF
484.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/245730
Citazioni
  • ???jsp.display-item.citation.pmc??? 34
  • Scopus 74
  • ???jsp.display-item.citation.isi??? 61
social impact